Switch from calcineurin inhibitors to belatacept in kidney transplant patients with chronic-active antibody mediated rejection results in lower decline in kidney function at three years - Archive ouverte HAL Access content directly
Journal Articles Journal of Nephrology Year : 2021

Switch from calcineurin inhibitors to belatacept in kidney transplant patients with chronic-active antibody mediated rejection results in lower decline in kidney function at three years

Tristan de Nattes
Arnaud François
  • Function : Author
Epidémiosurveillance de protozooses à transmission alimentaire et vectorielle
Sophie Candon
  • Function : Author
Isabelle Etienne
  • Function : Author
Charlotte Laurent
  • Function : Author
Marie Matignon
  • Function : Author
Antoine Morel
  • Function : Author
Johan Noble
  • Function : Author
Martin Planchais
  • Function : Author
Dominique Guerrot
  • Function : Author
Dominique Bertrand
  • Function : Author

Domains

Life Sciences [q-bio]

Venceslas VILLIER  : Connect in order to contact the contributor

https://hal-normandie-univ.archives-ouvertes.fr/hal-03751917

Submitted on : Tuesday, August 16, 2022-8:37:19 AM

Last modification on : Tuesday, February 28, 2023-2:20:10 PM

Not file

Dates and versions

hal-03751917 , version 1 (16-08-2022)

Identifiers

Cite

Tristan de Nattes, Arnaud François, Sophie Candon, Isabelle Etienne, Charlotte Laurent, et al.. Switch from calcineurin inhibitors to belatacept in kidney transplant patients with chronic-active antibody mediated rejection results in lower decline in kidney function at three years. Journal of Nephrology, 2021, 34 (6), pp.2159-2162. ⟨10.1007/s40620-021-01099-7⟩. ⟨hal-03751917⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

ANSES URCA COMUE-NORMANDIE ESCAPE-REIMS UNIROUEN ESCAPE-ROUEN
17 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More